DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/330598/bevacizumab_key) has announced the addition of the "Bevacizumab - Key ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Tofacitinib - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)" report to their offering. Need ...

No new PTSD drug approvals in the U.S. in nearly 25 years; large potential addressable market for SPC-15 worldwide SARASOTA, FL, July 07, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (SILO) (“Silo” or ...